Multiple newly identified loci associated with prostate cancer susceptibilityDouglas F. Easton, Rosalind A. Eeles, Zsofia Kote‐Jarai et al.|Nature Genetics|2008Cited by 850
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology SocietyAlexander R. Lyon, Teresa López‐Fernández, Daniel J. Lenihan et al.|European Journal of Heart Failure|2020Cited by 767
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experienceNora A. Janjan, John M. Skibber, Vincent Khoo et al.|International Journal of Radiation Oncology*Biology*Physics|1999Cited by 468
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBernard Escudier, Vesa Kataja, Tim Eisen et al.|Annals of Oncology|2012Cited by 275
A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapyChristopher M. Nutting, D.P. Dearnaley, Vincent Khoo et al.|Radiotherapy and Oncology|2000Cited by 53